Resveratrol treatment was also able to ameliorate motor and cognitive impairments in an A53T α-synuclein mouse model of PD by diminishing the levels of α-synuclein aggregates and reducing microgliosis, astrocytosis, and oxidative-stress levels within the brain [150]. Here, SNCA is linked to Cognitive impairment.